Jenny Rooke is the founder and managing director of Genoa Ventures, investing at the intersection of technology and biology. She has nearly two decades of investing experience, starting at Fidelity Biosciences and later helping establish the investing function at the Gates Foundation.
At firms with a similar stage, sector and check size.
One email when Jenny's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJenny Rooke is the founder and managing director of Genoa Ventures, investing at the intersection of technology and biology. She has nearly two decades of investing experience, starting at Fidelity Biosciences and later helping establish the investing function at the Gates Foundation.
Genoa Ventures has not reported a check size. It invests at seed.
A warm intro from a founder Genoa Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
executive management at U.S. Genomics; Georgia Institute of Technology; Yale University; U.S. Genomics; Gates Foundation; 5 Prime Ventures.
Last updated 2026-10-15. Is this you? Ask for a correction.